Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
This clinical trial studies bioelectrical impedance phase angle in predicting treatment outcome in patients with extensive stage small cell lung cancer receiving first-line chemotherapy. Diagnostic procedures, such as bioelectrical impedance analysis, may help predict a patient's response to treatment for small cell lung cancer.
Full description
PRIMARY OBJECTIVES:
I. To evaluate the association between phase angle (PA) measurement and progression-free survival (PFS).
SECONDARY OBJECTIVES:
I. To evaluate the association between PA measurement and treatment-related outcomes of treatment response, adverse treatment events, and overall survival (OS).
II. To determine the feasibility of obtaining PA measurements at a single time point in patients undergoing evaluation in thoracic oncology clinics.
OUTLINE:
Patients undergo bioelectrical impedance phase angle measurement on day 1 of treatment.
After completion of study treatment, patients are followed up every 2-3 months for two years.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
1 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal